TW201114894A - A novel promoter and applications thereof - Google Patents

A novel promoter and applications thereof Download PDF

Info

Publication number
TW201114894A
TW201114894A TW98136948A TW98136948A TW201114894A TW 201114894 A TW201114894 A TW 201114894A TW 98136948 A TW98136948 A TW 98136948A TW 98136948 A TW98136948 A TW 98136948A TW 201114894 A TW201114894 A TW 201114894A
Authority
TW
Taiwan
Prior art keywords
nucleic acid
recombinant vector
fish
seq
promoter
Prior art date
Application number
TW98136948A
Other languages
Chinese (zh)
Other versions
TWI396742B (en
Inventor
Jyh-Yih Chen
Kuan-Chieh Peng
Original Assignee
Academia Sinica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Academia Sinica filed Critical Academia Sinica
Priority to TW98136948A priority Critical patent/TWI396742B/en
Publication of TW201114894A publication Critical patent/TW201114894A/en
Application granted granted Critical
Publication of TWI396742B publication Critical patent/TWI396742B/en

Links

Abstract

The present invention relates to a novel promoter found in the upstream region of the myosin light chain-2 (mylz2) gene, and applications thereof. The promoter according to the invention exhibits an enhanced promoter activity, which is useful for producing transgenic animals, particularly fluorescent fish.

Description

201114894 六、發明說明: 【發明所屬之技術領域】 基因 本發明係關於來自斑馬魚肌凝蛋白輕鏈2 ( 2) 之新穎啟動子及其應用。 【先前技術】 基因触是現今生物科技領域廣泛應_技術,盆係細 術,透過人為操財式,將可表現狀基因 矣相導人動物體細胞或纽細胞巾,以修飾動物之基因 =或賦予_表現性狀。基轉殖技術是目前畜養業 產養殖積極運用的技術之一,特別是針對牛、 了: ^以改良品種、增加生長率、改良肉質' 一般而言,鱗人動健岐DNA = 調控其表現的啟動子序列。選擇適當的啟動子可^桿 =因依顺方式表現’進而_在轉殖基_ “ 鳴—嫩、娜麵、或提升的蛋白 故早基因體學起步較晚,累積的資訊不足, Ziii基因轉殖調控元件大多來自老鼠或病毒,使得 研办艾:2體^終究留有病毒來源之dna片段。近年來, 曰力全魚」(ali_fish)轉殖基因魚之研究,全备 ΐ 2欲轉_基因及所使用的各項調控元件均源自於^ :、使仵轉殖成功的魚類得以改變部份基因的 .規、 出所,期的特性,但不帶有源自其它物種的基因片工段。表現 俾岸此f域中,—直有需要尋求有潛力的啟動子, 皁應用於動物之轉殖基因技術,特別是魚類。 【發明内容】 201114894 传由方面本發明提供—齡離的核酸分子,其 。賊序騎喊。树明之分離的核 酸片ί另;m發明提供一種重組载體,其包含第-核 =段係由se⑽n〇: 1之核魏序列所 至也’本發明之重組载體尚包括第二核酸片段,1 =!;蛋,多狀:且f作地連接至第-核酸片ί。根 二 μ第一核I片#又係編碼一外源性之蛋白質戋多 編碼==質本發明之重組載體之第二核酸片段係 例,本發明之方法可用於製備轉殖基因魚,特別是勞 各個具體實例的㈣朗如後。本發明之其他 Si;rr各個具體實例中的詳細說明及申請專利範 僅是作為例示說明;而非‘何 實施方式】 段 士發明主要從斑馬魚mylz2基因之上游序列分離 、棱升活性的啟動子之核酸片段,可 明可利用該核酸片段製備轉殖i因動‘ ίίίί 限於魚類,特別是螢光魚- 匕栝仁不 201114894 本文所使用的「一」乙詞,如未特別指明,係指至少一 個(一個或一個以上)之數量。 本文所使用的「核酸分子」或「核酸」乙詞是指核苷酸 單體之聚合體,其可以是單股或雙股、直線型或環狀、去氧 核糖核酸(DNA)或核糖核酸(rna)。一核苷酸單體包括 磷酸基部分、糖基部分及鹼基部分。常見的核苷酸之鹼基部 分包括鳥糞嘌呤(G)、腺嘌呤(A)、胞嘧咬(C)、胸腺喷 啶(T)及尿嘧啶(u) ’其中腺嘌呤與胸腺嘧啶或尿嘧啶配 對’以及鳥翼°票1»令與胞喊唆配對。 本文所使用之「分離的核酸分子」係指從天然生物體來 源純化而來的核酸’或以化學合成法或PCR擴增技術所製得 的核酸。核睃之純化方法、化學合成法及PCR擴增技術可參 見 Molecular Cloning : A Laboratory Manual,第二版,c〇ld201114894 VI. Description of the Invention: [Technical Field to Which the Invention Is Applicable] Gene The present invention relates to a novel promoter derived from zebrafish myosin light chain 2 (2) and uses thereof. [Prior Art] Gene touch is widely used in the field of biotechnology. _Technology, basin-based techniques, through the human-fashioned way, can be expressed in the human body cells or Newton cell towels to modify the animal's genes = Or give _ performance traits. Base-transfer technology is one of the most actively used technologies in animal husbandry, especially for cattle. ^ To improve varieties, increase growth rate, and improve meat quality' In general, squamous human DNA regulates its performance. Promoter sequence. Choosing the appropriate promoter can be used as a function of the following method: 'In the _ _ in the _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ Most of the regulatory elements are from mice or viruses, which makes the research institute Ai: 2 body ^ after all, there is a virus-derived DNA fragment. In recent years, the study of ali_fish transgenic fish has been fully prepared. The genes and the regulatory elements used are derived from ^: the fish that have been successfully transferred to the scorpion can change the characteristics of some genes, but not with the genes from other species. Section. Performance In this f-domain, there is a need to find potential promoters, and soaps are used in animal genetic technology, especially fish. SUMMARY OF THE INVENTION The present invention provides an isolated nucleic acid molecule. The thief is riding a shout. The nucleic acid fragment isolated from the tree; the m invention provides a recombinant vector comprising a first-nuclear=segment from the nuclear sequence of se(10)n〇:1 to also the recombinant vector of the present invention further comprising a second nucleic acid fragment , 1 =!; egg, polymorphic: and f is connected to the first - nucleic acid fragment ί. Root two μ first nuclear I tablets #also encode an exogenous protein 戋 multi-code == quality of the second nucleic acid fragment of the recombinant vector of the invention, the method of the invention can be used to prepare transgenic fish, especially It is the specific example of the work (4). The detailed description and patent application of each of the other specific examples of the present invention are merely illustrative; rather than the embodiment of the invention, the section of the invention mainly separates from the upstream sequence of the zebrafish mylz2 gene and initiates the activity of the prismatic activity. The nucleic acid fragment of the nucleic acid fragment can be used to prepare the transcriptional fragment of the nucleic acid fragment. ίίίί is limited to fish, especially the fluorescent fish - 匕栝仁不201114894 The word "一" used in this article, unless otherwise specified, Refers to the quantity of at least one (one or more). As used herein, the term "nucleic acid molecule" or "nucleic acid" refers to a polymer of nucleomonomers which may be single or double stranded, linear or cyclic, deoxyribonucleic acid (DNA) or ribonucleic acid. (rna). A nucleomonomer includes a phosphate moiety, a glycosyl moiety, and a base moiety. Common bases of nucleotides include guano (G), adenine (A), cytosine (C), thymidine (T), and uracil (u) 'where adenine and thymine or Uracil pairing 'and bird wing ° 1» order paired with cell shouts. As used herein, "isolated nucleic acid molecule" refers to a nucleic acid that has been purified from a source of natural organisms or a nucleic acid produced by chemical synthesis or PCR amplification techniques. For purification methods, chemical synthesis methods and PCR amplification techniques of nuclear rafts, see Molecular Cloning: A Laboratory Manual, Second Edition, c〇ld

Spring Harbor Laboratory Press ’ SambrookJ 等人編著,1989,Spring Harbor Laboratory Press ’ SambrookJ et al., 1989,

以及 Current Protocols in Molecular Biology,Frederick M.A 4 人編著 ’ 2001 ’ John Wiley & Sons,Inc.。此一領域具通常 知識者可依據習知的技術獲得本發明之核酸分子,詳^方法 描述於以下實例中。 本文所使用之「可操作性地連接」或類似用語是指調節 性序列與另一編碼特定基因產物之核苷酸序列的連接方式, 使得該核苷酸序列接受調節性序列之控制或調節,而在適當 條件下表現出該基因產物。 胃 本文所使用的「重組」係用以描述核酸分子含有非天然 連接的序列。重組核酸分子可為載體形式,其可包括一或多 個編碼基因之結構序列及用於表現該基因之調節性序列,例 如’啟動子序列。載體之種類包括但不限於質體、黏質體、 嗟菌體、YAC或PAC等。重喊體可驗表現或複製所導 入的基因序列。典型地,在重組載體中’編碼基因之結構序 列係操作性地連結於調節性序列,使得重組載體導入適當宿 主中時,編碼基因之結構序列在該調節性序列之調控下表 201114894 現。調節性序列可包括但稀於啟動子相、起 複製起始點或分泌訊息序列等。 。在馬于 # 核ΐίΓ編碼...」或其類似用語是 列^可在適當條件下作為模板表現出該基因產 的疋’由於基因进碼(由三個核芽酸所組成)之簡併性:、 不同的基因密碼可編碼相同的胺基酸殘基,例如,G 血 r即天 =(==的:編產:=基酸殘 通常,識:可運用例行技術及已知的基因密碼偏== usage),獲得對應的核苷酸序列及其簡併序列。因此, 之㈣酸序列尚包括其簡併序列(可 ω =提供—種分剌賊分子,其係由seq 早序麟組成。具體㈣,本發明之核酸分 imylz2基因之上游序列,其長度為现 有,升的啟動子活性’可用於表現操作性地連接於立上 H因^。根據本發明實施例,該核酸分子與其他啟動子 夕二^具較佳之啟動子活性;尤其較L9 kb啟動子片段 之活性尚出約2.8倍之多(如實例3所列)。 乃 酸另^面’本發明提供—種重喊體,其包含第一核 S ϋ核酸片段係由seqidn〇: 1之㈣酸序列所 复im’本發明之重組賴進—步包含第二核酸片段, 明U =且操作性地連結至第一核酸片段。根據本發 =二核酸片段表現係由第一核酸片段調控。根據本發 現性酸片段可為㈣浦之錢表現或賦予新的表 2 增加生長率、改良肉質、提高抗病能力及適 才i中,楚,Γ1色、或提升觀賞價值等。本發明一具體實施態 外源卷占二玄酸片段係編碼一外源性蛋白質或多肽,例如該 '、蛋白貝可為冷城營光蛋白質俾製成觀賞魚,或該外源 201114894 蛋源蛋白等俾製成抗病魚增加魚類生存活力。 母^ϊ ίί料包括但不限於敎蟲冷光酶及水 ^綠替# 蛋自包括但不限於綠#光蛋自(gfp)、 )、紅螢光蛋自(卿)、黃®光蛋白(YFP) 二列如’強化型繼蛋白(EGFP)、強化型 ( wp)。此等蛋白之胺基酸及核織列已 ί 者。例如,紅螢光蛋白具有SEQIDN〇: 2之 核狀士列,SEQ ID NO: 3之胺基酸序列(圖4 )。And Current Protocols in Molecular Biology, Frederick M.A 4 authored '2001 ' John Wiley & Sons, Inc. The nucleic acid molecules of the present invention can be obtained by those skilled in the art in accordance with conventional techniques, and the methods are described in the following examples. As used herein, "operably linked" or similar terms refers to the manner in which a regulatory sequence is linked to another nucleotide sequence encoding a particular gene product such that the nucleotide sequence is subjected to the control or regulation of regulatory sequences, The gene product is expressed under appropriate conditions. Stomach As used herein, "recombinant" is used to describe a sequence in which a nucleic acid molecule contains a non-natural link. The recombinant nucleic acid molecule can be in the form of a vector which can include one or more structural sequences encoding the gene and regulatory sequences for expression of the gene, such as a 'promoter sequence. The types of carriers include, but are not limited to, plastids, vesicles, bacilli, YAC or PAC, and the like. The screaming body can perform the performance or copy the introduced gene sequence. Typically, in the recombinant vector, the structural sequence of the coding gene is operably linked to a regulatory sequence such that when the recombinant vector is introduced into a suitable host, the structural sequence of the coding gene is regulated in the regulatory sequence of the regulatory sequence. Regulatory sequences can include, but are dilute to, the promoter phase, the origin of replication, or the sequence of secretion messages. . In Ma Yu #核ΐίΓ编码..." or a similar term thereof is a column that can be used as a template under appropriate conditions to express the gene's 疋' due to the degeneracy of gene coding (consisting of three nuclear phytic acids) Sex: Different gene codes can encode the same amino acid residue, for example, G blood r is day = (= =: production: = base acid residue usually, knowledge: can use routine techniques and known The gene code is biased == usage) to obtain the corresponding nucleotide sequence and its degenerate sequence. Therefore, the (4) acid sequence still includes its degenerate sequence (may be ω = provide - the species scorpion thief molecule, which is composed of seq early sequence lin. Specifically (four), the nucleic acid of the present invention is the upstream sequence of the imylz2 gene, and its length is In the prior art, the promoter activity of liters can be used to express operably linked to the H. According to an embodiment of the invention, the nucleic acid molecule has better promoter activity with other promoters; in particular, L9 kb The activity of the promoter fragment was about 2.8 times higher (as listed in Example 3). The present invention provides a shamming body comprising a first nuclear S ϋ nucleic acid fragment by seqidn〇: 1 The (4) acid sequence of the im-recombination of the present invention comprises a second nucleic acid fragment, U = and operably linked to the first nucleic acid fragment. According to the present invention, the second nucleic acid fragment is expressed by the first nucleic acid fragment. According to the present invention, the discovery acid fragment can be (4) the performance of the money or give a new table 2 to increase the growth rate, improve the meat quality, improve the disease resistance and the ability, the color, the color, or enhance the ornamental value. A specific implementation state of the external volume accounted for two The acid fragment encodes an exogenous protein or polypeptide, for example, the protein shell can be made into an aquarium fish, or the exogenous 201114894 egg protein can be made into a disease-resistant fish to increase fish viability. Mothers ϊ ί ί 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 YFP) Two columns such as 'enhanced secondary protein (EGFP), enhanced (wp). The amino acids and cores of these proteins have been woven. For example, the red fluorescent protein has the nucleus of SEQ ID NO: 2, the amino acid sequence of SEQ ID NO: 3 (Fig. 4).

>,特定實例中,本發明之重組載體包含SEQ ID NO: 4 ί二列’其涵蓋SEQlDN〇: 1之核普酸序列(啟動子) 及、為碼紅螢光蛋白之SEQ ID NO: 2核苷酸序列。 進—*綱,本發明之紐尚可視需要地包括其他具 有特定功能之序列,例如,複製起始點、終止序列、供篩選 =途之標記基因,例如,抗生素抗性基因等。此—領域具通 t知ί者!^現有知識選擇適當的序歹1J,使用習知的遺傳工 私技術構齡發明之載體。觀重喊體所紐㈣遺傳工 程技術,例如,聚麵_反應(pCR)擴增技術、核酸純 化、載體及核酸片段之酵素處理及定序技術,可參見前述 Molecular Cloning : A Laboratory Manual A Current Protocols mMolecularBiology (同上;)。具體的載體構築細節說明於以 下的實例中。 因此,在又一方面,本發明提供一種製備轉殖基因動物 之方法,其包含將此處所述之重組載體導入動物細胞中。 根據本發明’此處所述「轉瘦基因動物」包括但不限於 牛、羊、豬、魚、蝦等不包含人顓之動物。特定而言,根據 本發明之轉殖基因動物是魚類,更特定而言,為科學上或商 業上有應用價值的魚種,包括但不限於斑馬魚(Zebraflsh, 如Z)細b rmb)、神仙魚(angelflsh,如七彩神仙(discuss)、 )、青鱗魚(me(jaka )、金魚(goldfish )、缠魚 201114894 (carp)、錦雜(koi),泥鞦(i〇ach)、吳郭魚(行1叩诅)、玻璃 魚(glassfish),餘魚(catflsh),鰻(eel)、紅蓮燈(tetra)、 蝦虎(goby)、攀驢科淡水魚(g〇urami)、孔雀魚(gUppy)、 劍魚(Xiphophorus )、茉莉魚(Molly fish )及,鲶魚(pangasius )。 在一特定實例中,根據本發明之轉殖基因動物是斑馬魚。 本發明之方法可利用已知的轉殖基因標準技術 ,例如顯 微注射(microinjection)、電破法(eiectroporation)、病毒載 體法(virus infection)及精子載體法(sperm_mediated gene transfer)等方法’迫使本發明之核酸分子進入動物之配子、 受精卵、胚胎或體細胞的細胞核或細胞質内,使本發明核酸 分子能在胚胎或細胞中繼續複製,進而在個體及其後代細胞 上表現’製得轉殖基因動物。 在了特定實例中,根據本發明之轉殖基因動物是斑馬 ^、’其係使雌微注射技術將重組載體導人魚彡卩細胞中而製 得、。進一^説明,使用毛細針吸取適當體積的重組載體,將 其注射於單細胞時期之斑馬魚受精纟卩,將注射完之A卵集中 於乾淨培養皿裡,至於28ΐ培養箱培養,約48 2'時 出魚苗。 了予 此一領域已發展出各種習知方法辨別或篩選帶有轉殖基 因的動物。例如’設計可辨認轉殖基因之探針,以北方墨潰 法(Northern blotting)或南方墨潰法(s〇她embl〇tting)來 偵測候選動物中是否具有轉絲因的序列,或以pcR針對特 定核酸糊放大的方式進行_。敎 之動物可直_眼睛觀察。 π⑽尤蛋白 在了特定實例巾,本發明之方絲將編碼螢光蛋白 組載體導入受精魚即中,姐於表接w , 出螢光的轉殖制Γ 德,直她_選發 本發明之各個具體實例的細節制後 ==了各個具趙實例中的詳細說明及^ 201114894 實例1 :基因组DNA之萃取 本實驗採用斑馬魚(Zebrafish,i)a«z〇rm〇)為材料,使 用商業套組 PureLink™ Genomic DNA Mini Kit (Invitrogen, 美國)萃取基因組DNA。簡言之,將組織放入微量試管之中, 加入PureLinkTM基因組消化缓衝液和蛋白酶κ,於55〇C條件 下分解組織,其間偶爾的震盪,均勻試劑,直至組織完全分 解,過程約1至4小時。之後在室溫下離心,取上清液置於 新的微量試管,加入RNase A,輕微的震盈,靜置室溫2分 鐘。加入200 μΐ的pureLinkTM基因組瓦解/結合緩衝液,混合 均勻後’再加入酒精(96-100%),震盪混合。將溶解產物以 離心的方式通過管柱過遽,清洗後,加入二次水或pureLinkTM 基因組沖提緩衝液,靜置後離心,獲得純化的基因組DNA。 實例2:啟動子片段之選殖 設計正反引子,交由生工有限公司及台灣生醫聯盟合成, 引子序列如下:____ 弓I子名稱.__序歹|J__ 5'mylz2 2.5kXhol CGCTCGAGATGCTGTGAAGTATTCTCTACTT _ (SEQ ID NO: 5)>, In a specific example, the recombinant vector of the present invention comprises the SEQ ID NO: 4 column, which covers the nucleotide sequence (promoter) of SEQ1DN〇: 1 and SEQ ID NO of the code red fluorescent protein: 2 nucleotide sequence. In addition, the novel of the present invention may optionally include other sequences having a specific function, for example, an origin of replication, a termination sequence, a marker gene for screening, for example, an antibiotic resistance gene, and the like. This is the domain that has the knowledge of t knowing! ^ The existing knowledge selects the appropriate sequence 1J, using the carrier of the conventional genetic engineering technology. (4) Genetic engineering techniques, such as polyhedral-reaction (pCR) amplification techniques, nucleic acid purification, enzymatic treatment of nucleic acids and nucleic acid fragments, and sequencing techniques, see Molecular Cloning: A Laboratory Manual A Current Protocols mMolecular Biology (ibid.). Specific carrier construction details are illustrated in the following examples. Accordingly, in yet another aspect, the invention provides a method of making a transgenic animal comprising introducing the recombinant vector described herein into an animal cell. According to the present invention, "transgenic animal" as used herein includes, but is not limited to, cattle, sheep, pigs, fish, shrimp, and the like which do not contain human lice. In particular, the transgenic animal according to the present invention is a fish, more specifically a fish species that is scientifically or commercially useful, including but not limited to zebrafish (Zebraflsh, such as Z) fine b rmb), Angelfish (angelflsh, such as colorful discos, ), blue scale fish (me (jaka), goldfish (goldfish), wrapped fish 201114894 (carp), jin (koi), mud autumn (i〇ach), Wu Guo Yu (1 叩诅), glassfish, catflsh, eel, tetra, goby, 〇 ami ami, gypnus (gUppy), swordfish (Xiphophorus), mulberry fish (Molly fish), and squid (pangasius). In a specific example, the transgenic animal according to the present invention is a zebrafish. The method of the present invention can be utilized. Standard techniques for transgenic genes, such as microinjection, eiectroporation, virus infection, and sperm-mediated gene transfer, to force the nucleic acid molecules of the invention into animals Gametes, fertilized eggs, embryos Within the nucleus or cytoplasm of a somatic cell, the nucleic acid molecule of the invention can continue to replicate in the embryo or cell, thereby producing a transgenic animal on the individual and its progeny cells. In a particular example, the transformation according to the invention The cloning animal is made by zebra, which is made by the female microinjection technique to introduce the recombinant vector into the squid cell. In a further description, the appropriate volume of the recombinant vector is aspirated using a capillary needle and injected into the single cell stage. The zebrafish are fertilized, and the injected A eggs are concentrated in a clean petri dish. As for the 28-inch incubator, the fry are produced at about 48 2'. Various conventional methods have been developed to identify or screen the bands. Animals with a transgenic gene, such as 'design a probe for recognizable transgenic genes, to detect whether there is a turn in the candidate animal by Northern blotting or Southern blotting (s〇 her embl〇tting) The sequence of silk, or the amplification of pcR for a specific nucleic acid paste. The animal of 敎 can be observed directly by eye. π(10) 尤 protein is in a specific example towel, the square wire of the present invention will The code fluorescent protein group vector is introduced into the fertilized fish, and the sister is connected to the table, and the fluorescent system is transferred to the sputum, and the _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ Detailed description and ^ 201114894 Example 1: Extraction of genomic DNA This experiment uses zebrafish (Zebrafish, i) a «z〇rm〇) as a material, using the commercial kit PureLinkTM Genomic DNA Mini Kit (Invitrogen, USA) Genomic DNA. Briefly, put the tissue into a microtube, add PureLinkTM Genomic Digestion Buffer and Protease κ, and decompose the tissue at 55 °C with occasional shaking, uniform reagents, until the tissue is completely decomposed, the process is about 1 to 4. hour. After centrifugation at room temperature, the supernatant was placed in a new microtube, RNase A was added, and a slight shock was applied. The mixture was allowed to stand at room temperature for 2 minutes. Add 200 μΐ of pureLinkTM genome disruption/binding buffer, mix well, then add alcohol (96-100%) and mix by shaking. The lysate is passed through a column by centrifugation. After washing, secondary water or pureLinkTM genome extraction buffer is added, and after standing, it is centrifuged to obtain purified genomic DNA. Example 2: The promoter design of the promoter fragment was synthesized by the Biotech Co., Ltd. and the Taiwan Biomedical Union. The sequence of the primer is as follows: ____ bow I subname.__序歹|J__ 5'mylz2 2.5kXhol CGCTCGAGATGCTGTGAAGTATTCTCTACTT _ (SEQ ID NO: 5)

3’ mylz2 2.5k A%el CGGCTAGCGTAGTGTCCTGTACTTGAGGGGC (SEQ ID NO: 6) _ --- 以斑馬魚基因組DNA為模板,在PCR離心管中添加上述 正反引子、DNA聚合酶、 如下: 緩衝液、dNTPs等試劑,含量 試劑 含量 基因組DNA 100 ng 10X ThermoPd反應緩衝液 2.5 μΐ lOmMdNTP 2 μΐ 5〇 μΜ 引子(5' my/z2 2.5k ^T2c>I) 0.25 μΐ 201114894 50 μΜ 引子(3' —/z2 2.5kM^I) 0.25 μΐ DNA 聚合酶(5 υ/μΙ〇 0.25 μΐ ddH20 加滿至總體積為25 μΐ -- 丨- 將上述PCR離心管移至PCR反應器(Applied Biosystems 2700,美國),進行PCR反應,其條件為:起始變性反應為 94°C 5分鐘’變性、黏合及延伸反應之循環為94°C 30秒、55°C 30秒及72°C 2分鐘,重複35個循環,最後延伸反應為72°C 10 分鐘’最後置於4°C終止反應。PCR反應結束後,以瓊脂膠體 電泳分析PCR產物,再將含有預測大小的PCR產物片段之 膠體切下,以商業套組 Gel/PCRDNA Fragments Extraction Kit (Geneaid, Taiwan),獲得純化的PCR產物。 將純化的PCR產物選殖至pCRII-TOPO-TA載體 (Invitrogen),先經由轉殖菌株之抗生素篩選,再由台北基龍 米克斯生物科技股份有限公司以核酸序列自動定序儀 (autosequencer, ABI)進行定序工作,從5,端及3,端進行至少 兩次定序分析,選出品系,確認其含有重組載體 pCRII-mylz2-2.5k,該重組載體帶有核苷酸序列為SEQIDNO: 1之啟動子片段,下稱「2.5kb啟動子月段」。圖1顯示2.5kb 啟動子片段之核苷酸序列(-1至-2504)。 實例3 :冷光酶重组載艘之構築及啟動子活性分析 以上述重組載體pCRII-mylz2 2.5k為模板,分別使用下列 5’端引子之其中一種,加上3,端引子,以PCR增幅出2.5 kb 竺叟及其截短片段(2.3kb、2.1kb及1.9kb): _3' mylz2 2.5k A%el CGGCTAGCGTAGTGTCCTGTACTTGAGGGGC (SEQ ID NO: 6) _ --- Using the zebrafish genomic DNA as a template, add the above-mentioned positive and negative primers, DNA polymerase to the PCR tube, as follows: Buffer, dNTPs, etc. Reagent, content reagent content genomic DNA 100 ng 10X ThermoPd reaction buffer 2.5 μΐ lOmMdNTP 2 μΐ 5〇μΜ primer (5' my/z2 2.5k ^T2c>I) 0.25 μΐ 201114894 50 μΜ primer (3' –/z2 2.5kM ^I) 0.25 μΐ DNA polymerase (5 υ/μΙ〇 0.25 μΐ ddH20 is filled up to a total volume of 25 μΐ - 丨- Move the above PCR tube to a PCR reactor (Applied Biosystems 2700, USA) for PCR reaction The conditions are as follows: the initial denaturation reaction is 94 ° C for 5 minutes. The cycle of denaturation, bonding and extension reaction is 94 ° C for 30 seconds, 55 ° C for 30 seconds and 72 ° C for 2 minutes, repeating 35 cycles, and finally extending. The reaction was 72 ° C for 10 minutes. Finally, the reaction was terminated at 4 ° C. After the end of the PCR reaction, the PCR product was analyzed by agar gel electrophoresis, and the colloid containing the PCR product fragment of the predicted size was cut out to commercialize Gel/ PCRDNA Fragments Extraction Kit ( Geneaid, Taiwan), obtained purified PCR product. The purified PCR product was cloned into pCRII-TOPO-TA vector (Invitrogen), first screened by antibiotics of the transgenic strain, and then limited by Taipei Kelonex Biotechnology Co., Ltd. The company uses the nucleic acid sequence autosequencer (ABI) for sequencing work. At least 5 sequences are analyzed from the 5th and 3rd ends, and the strain is selected to confirm that it contains the recombinant vector pCRII-mylz2-2.5k. The recombinant vector carries a promoter fragment having the nucleotide sequence of SEQ ID NO: 1, hereinafter referred to as "2.5 kb promoter month." Figure 1 shows the nucleotide sequence of the 2.5 kb promoter fragment (-1 to -2504). Example 3: Construction of luminescent enzyme recombination carrier and promoter activity analysis Using the above recombinant vector pCRII-mylz2 2.5k as a template, one of the following 5' primers was used, plus 3, and the primer was used to increase the PCR by 2.5. Kb 竺叟 and its truncated fragments (2.3kb, 2.1kb and 1.9kb): _

myiz2 2·5Κ 5' Sacl CGGAGCTCATGCTGTGAAGTATTCTCTA _____(SEQ ID NO: 7)Myiz2 2·5Κ 5' Sacl CGGAGCTCATGCTGTGAAGTATTCTCTA _____(SEQ ID NO: 7)

mylz2 2*3K 5' Sacl CGGAGCTCTACTAATTGATGATTAGTTT ___ (SEQ ID NO: 8) 201114894 mylz2 2.1K5'&amp;cI CGGAGCTCTTGCCAGTTTAGTTCAGTCA __(SEQIDNO: 9) mylz2 1.9K 5' Sacl CGGAGCTCGTGTATTTTTTATGCAGCGG (SEQIDNO: 10) mylz2 promoter 3' Xhol CGCTCGAGGTAGTGTCCTGTACTTGAGG ___(SEQIDNO: 11) 將各種長度之啟動子片段分別選殖至pGL3基礎冷光報導 載體(Promega ’美國)’獲得含有不同長度之啟動子片段之重 組pGL3載體。使用表現水母冷光酶基因之pRL_TK載體做為 内部對照組,以1 : 1之比例,分別與前述重組^^]^載體(含 有不同長度之啟動子片段)或pGL3基礎載體(不含啟動子片 段)混合後,以顯微注射法,導入單細胞時期之斑馬魚受精卵。 使受精卵在28°C培育72小時,以商業套組Dual_Ludferase⑧ Repose二Assa:System (Promega ’ 美國)測量啟動子活性。 簡言之’每組取10個健康胚胎,加入5〇 μ1被動裂解緩衝 液(passive lysis buffer) ’在冰上磨碎。離心1〇分鐘,取上 = 5〇μ1冷光酶分析試劑π (遣1]〇混合,使用冷光 儀(HU〇=Skan Ascent FL lumin_ter,Therm〇 ―挪咖, ^ 2顯示啟動子活性分析絲。數據係以平 ㈧Ας&quot;τ .壬現’共進行三重複實驗,使用SAS統計程式 &lt;〇二二=祕美國〕,統計上的顯著性設定於ρ&lt;〇·〇5 i H植據仙單13子變異數分析(an〇va)進行ί 其礎賊動刊段㈣照組載體(PGL3 J JPGL3 高==·批軸恤,2.5㈣㈣珊之活性約 201114894 實例二轉殖基因魚(螢光魚)之製備 仗月述重組載體pCRII_mylz2 2 5k切下2 5处啟動子片 ί,二接1可表現紅營光之―1^2·1載體(C1_ch,美國), 挑L正確品系,獲得Pmylz2 2.5K-DsRed重組載體(圖3)。 / „針吸取射體積的重組碰(敍*超過30 劑(最終》農度為約2%的紛紅),對單細胞時 =斑讀㈣行顯微注射。將注射完之魚_中於乾淨 培養皿裡,加4氣树坑培偏轉。每天檢杳發育产 形並挑出發育失敗之料,待街2小^母^紅月清 备,魚,,觀表現從中挑選6隻轉殖基因候選 :6『二雄魚2號、雄魚3號、雄魚5號、雄 :別與野生型斑馬魚進行交配。轉殖 基因候選魚之$光魚子代產出率分別為· 18 23% Ο%。、〇%、0%和5.88%,其中又以雌魚丨號之螢0 現隶強。繼而從雌备1沪之F1巾茲 的螢先表 又,純化並穩定品系,至少可繼續繁衍 自 =一㈣。該定 更甚者在吻部亦有_f絲現;相: 魚’腹部無明顯營光表現= 因,相ΐ於之响基 於水產動物之顧轉殖研究有極大助益^^製,,特別對 製備上有顯著提升營光表現之效果 ^ 在勞光魚之 貢獻。 τ、硯貝魚之產業有相當 無須進一步的闡述,咸相信本發明 常知識者基於前述說明即可利用本發明至最^中^有通 201114894 ί==ί僅是作為例示說明之用 ,而非以任何方 【圖式簡單說明】Mylz2 2*3K 5' Sacl CGGAGCTCTACTAATTGATGATTAGTTT ___ (SEQ ID NO: 8) 201114894 mylz2 2.1K5'&amp;cI CGGAGCTCTTGCCAGTTTAGTTCAGTCA __(SEQIDNO: 9) mylz2 1.9K 5' Sacl CGGAGCTCGTGTATTTTTTATGCAGCGG (SEQIDNO: 10) mylz2 promoter 3' Xhol CGCTCGAGGTAGTGTCCTGTACTTGAGG ___ (SEQ ID NO: 11) Promoter fragments of various lengths were separately selected into the pGL3 basal luminescence reporter vector (Promega 'United States)' to obtain recombinant pGL3 vectors containing promoter fragments of different lengths. The pRL_TK vector expressing the jellyfish luciferase gene was used as an internal control group, and the recombinant vector (containing a promoter fragment of different length) or the pGL3 basic vector (without the promoter fragment) in a ratio of 1:1, respectively. After mixing, the zebrafish fertilized eggs were introduced into the single cell stage by microinjection. The fertilized eggs were incubated at 28 ° C for 72 hours, and the promoter activity was measured in a commercial kit Dual_Ludferase 8 Repose II Assa: System (Promega ' USA). Briefly, '10 healthy embryos per group were added and 5 〇 μ1 passive lysis buffer was added to grind on ice. After centrifugation for 1 minute, a mixture of = 5 〇 μ1 luminescence enzyme analysis reagent π (1) was mixed, and a cold light meter (HU〇=Skan Ascent FL lumin_ter, Therm〇-Noga, ^ 2) was used to display the promoter activity analysis filament. The data is based on the flat (eight) Ας &quot; τ. 壬 now 'total three repeated experiments, using the SAS statistical program < 〇 二 = = secret US], statistical significance set in ρ &lt; 〇 · 〇 5 i H plant 13 sub-variant analysis (an〇va) for ί 础 贼 贼 ( ( 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四Preparation of fish) Recombinant vector pCRII_mylz2 2 5k cut 2 5 promoter fragments ί, 2 connected 1 can express the red camp light ―1^2·1 vector (C1_ch, USA), pick L correct strain, get Pmylz2 2.5K-DsRed recombinant vector (Fig. 3). / „Retraction of the needle volume (reduced by more than 30 doses (final) is about 2% of the redness), for single cells = spot reading (four) Microinjection. Inject the fish into the clean petri dish, add 4 gas tree pits and deflect it. Check the developmental shape and pick it every day. The material of developmental failure, waiting for the street 2 small ^ mother ^ red moon clearing, fish, and performance performance from which to select 6 transgenic gene candidates: 6 "two male fish 2, male fish 3, male fish 5, Male: Do not mate with wild-type zebrafish. The yield of the light-breeding progeny of the transgenic gene candidate fish is 18 23% Ο%, 〇%, 0%, and 5.88%, respectively. The firefly 0 is now strong. Then from the female preparation 1 Shanghai F1 towel, the first table, purified and stabilized the line, at least continue to multiply from one (four). The more even in the snout is also _f silk Now; phase: fish 'abdominal no obvious camp light performance = because, the sound of the sound based on the aquatic animal transfer research has great help ^ ^ system, especially for the preparation of the effect of significantly improving the performance of the camp ^ In the contribution of Laoguangyu. The industry of τ and mussels has considerable need for further elaboration. I believe that the inventors of the present invention can use the present invention based on the foregoing description to the best of them. 201114894 ί==ί is only Used as an illustration, not by any means [simplified description]

ID 及二11示现啟動子片段之核_序列(SEQ 酸位置。)。數予代表轉譯触位置ATG向上料算之核芽 圖2顯示本發明之2.5kb啟動子片段之冷光酶活性分析 結果。ID and 2 show the nuclear_sequence of the promoter fragment (SEQ acid position.). Numerous buds representing the translational touch position ATG up-counting Figure 2 shows the results of cold-light enzyme activity analysis of the 2.5 kb promoter fragment of the present invention.

圖3顯示根據本發明之用於製備轉殖基因魚之 pm2‘5K-DsRed重組載體之結構圖。 ^ 圖4顯示pm2.5K-DsRed重組載體編碼之紅勞光蛋白之 核苷酸序列(SEQ ID NO: 2 )及胺基酸序列(SEQ ID NO: 3 )。 圖5A及5B顯示pm2.5K-DsRed重組載體編竭之啟動子 至紅螢光蛋白之核苷酸序列(SEQIDNO:4)。Fig. 3 is a view showing the structure of a pm2 '5K-DsRed recombinant vector for preparing a transgenic fish according to the present invention. Figure 4 shows the nucleotide sequence (SEQ ID NO: 2) and the amino acid sequence (SEQ ID NO: 3) of the red light photoprotein encoded by the pm2.5K-DsRed recombinant vector. Figures 5A and 5B show the nucleotide sequence of the pm2.5K-DsRed recombinant vector-expressed promoter to red fluorescent protein (SEQ ID NO: 4).

13 201114894 序列表 &lt;11 〇&gt;中央研究院 &lt;120&gt;新穎啟動子片段及其應用 &lt;160〉 11 &lt;170&gt; Patentln version 3.313 201114894 Sequence Listing &lt;11 〇&gt; Academia Sinica &lt;120&gt; Novel promoter fragment and its application &lt;160〉 11 &lt;170&gt; Patentln version 3.3

&lt;210&gt; 1 &lt;211&gt; 2504 &lt;212&gt; DNA &lt;213&gt; 斑馬魚(Ζ&gt;α/Η·ο rerii)) &lt;220&gt; &lt;223〉2.5 kb 啟動子&lt;210&gt; 1 &lt;211&gt; 2504 &lt;212&gt; DNA &lt;213&gt; Zebrafish (Ζ&gt;α/Η·ο rerii)) &lt;220&gt;&lt;223>2.5 kb promoter

atgctgtgaa aaaatgttaa attgactaac caaatctctg cagggagtat taattcctca tctagcctga ttgggggatg atgaaaaagt aggcttagtc gtgtattttt atctgtcttt acattagatt accttttcaa tattagtgcc ccttgaggtt cccagtgaca caaaataact aatattaaat aattgttcaa gttttatctt tctgttttgt tattcatttt taggtactgt ccgacagact aagggggaca gattgtttag actgtcttaa tagtgtgctg agcttcccac cggcagagag gggtgtggtg aaaacctatt tatatatcag ctggattgaa caagataagc tttagactct caaacagtcc gtattctcta atgaagggat agcaattcag gacaactaca actacaatat atcaaatatc tctcaagaga agcaaatcat tacaaatttg cctttattaa tatgcagcgg taaattaata agtcagtaca aaggtacata taaaaatttt ttattatgga gtttacaccc tatgataacg acaaatttta aatttgtagg tcaattttgt ttaaatgcac caaaatgggc aaaataatgc cacaggatat aaacagtgac ctattttggt gcctcaaatt accatctaaa aaatggcacc agagagagag ggggcacttg ttcgattagg ccaggggcgt atccatcagg cagtattgat gtggctacag cttacgtccc cttatcttaa attttcaaag ctacaattca tactaattga aaatacgata accccatatg aaacgcgagt actaaaatgt tgttgacccc tcaggattcg atgcccatcc tttttaatag ctctcagaaa tttgtactta aagagaaaca cctttaaggt tttatttctg gtccaaaaac aaacagggaa ttgtaatttt gactaaaata caaaatacat tgtactcgat taatcttaaa caaattagtc tgatgaatta cacccacagc tctcttcatg aactgggaaa tcacagtcac agagagagag aaccgaaatc gctgatttga gaacaaatat atctatcact ctgctgctaa ctcattcatt catgtcctta ttctctaaaa ccaatcgact agtaatgttc tgattagttt aaacttgtga tcccatgctc attttatgtt acgaattagt tcacaaatct ccacagagga agttgcagcc gaagctatac taaaggtgcg aagggtccat cttttgtact acaaattttt agagtgaagc tactacaccc aaatcaagag tttgttgcaa ttattttaat tgcctatatt tactctgagc caattttgga taaagaaaga gacaagaaaa tgttccttat agggtccaac aaggggtaat tgaagtgacc agtgctgaat ttacagcatc aataagggtt gaacaacata gcaaccctcc tctaacttta tcaaattgag ttagtcaacg ataatgcaaa tttagaatag tgaagataga aaacctatta gcatgtatta agcatatatg ttgccagttt tcgtacgaat gtcttcattc atgagccacc ctacactggg aatgttatat caagctgtca attgatacct ttttaggtac atcatttgga taaatctgga atatttatat aagcaaaaca tatttagctt aaatatagct cactgagaga actgtaatta acaagaagga agggaatgca agagagcaag gcctgccttc atcaaccact tacgtgcttg gggtgaggtc atgggcatgg actatactag aagacaccag atcattggct ccatccaaca ggggagggag ttatgtgatt cgagacatgc agtattcttt ataatgttta tatgagttaa ttttacatta aagcaattaa agtacacccc agttcagtca tagccactaa attttctttt aactcatcca aaacacccaa ttgtgcatat ctgcggtggt caaaagtata taatatatac aaggtaccac gcttatttaa gttattgaaa atggaaaaaa tatttaaatt gtttaataaa tggagaaaaa tctgtttttc gcaaaacaag caacaaactc gagcgctcaa ccaaaaaaaa cagagggctg tccacagggc ataggtcgat ccatgtggac gaaaagcatt aacgtcctct caaaaaatct agtaatcctg ttgcgtcccc gtatgaagct aggccgctgc 60 120 180 240 300 360 420 480 540 600 660 720 780 840 900 960 1020 1080 1140 1200 1260 1320 1380 1440 1500 1560 1620 1680 1740 1800 1860 1920 1980 2040 2100 2160 2220 2280 1 201114894 catcagtatc agattcatcc cattccaaga ctccaatagc tatttctgag cactgtaaga 2340 tgatagtaca tcccagccgg tgtccctcca tcactttccc cctacctcat agttttgcct 2400 ctttctctct cggtctgcta tttcccaaac ctcacttaag gttgggtcta taattcgcaa 2460 ggggccttcg tcagtatata agcccctcaa gtacaggaca ctac 2504 &lt;210&gt; 2 &lt;211&gt; 678 &lt;212&gt; DNA &lt;213&gt; &lt;220〉 &lt;223&gt;紅螢光核苷酸序列 &lt;400&gt; 2 atggcctcct ccgagaacgt catcaccgag ttcatgcgct tcaaggtgcg catggagggc 60 accgtgaacg gccacgagtt cgagatcgag ggcgagggcg agggccgccc ctacgagggc 120 cacaacaccg tgaagctgaa ggtgaccaag ggcggccccc tgcccttcgc ctgggacatc 180 ctgtcccccc agttccagta cggctccaag gtgtacgtga agcaccccgc cgacatcccc 240 gactacaaga agctgtcctt ccccgagggc ttcaagtggg agcgcgtgat gaacttcgag 300 gacggcggcg tggcgaccgt gacccaggac tcctccctgc aggacggctg cttcatctac 360 aaggtgaagt tcatcggcgt gaacttcccc tccgacggcc ccgtgatgca gaagaagacc 420 atgggctggg aggcctccac cgagcgcctg tacccccgcg acggcgtgct gaagggcgag 480 acccacaagg ccctgaagct gaaggacggc ggccactacc tggtggagtt caagtccatc 540 tacatggcca agaagcccgt gcagctgccc ggctactact acgtggacgc caagctggac 600 atcacctccc acaacgagga ctacaccatc gtggagcagt acgagcgcac cgagggccgc 660 caccacctgt tcctgtag 678 &lt;210〉3 &lt;211&gt; 225 &lt;212&gt;蛋白質 &lt;213&gt; &lt;220&gt; &lt;223&gt;紅螢光胺基酸序列 &lt;400&gt; 3 MASSENVITE FMRFKVRMEG TVNGHEFEIE GEGEGRPYEG HNTVKLKVTK GGPLPFAWDI 60 LSPQFQYGSK VYVKHPADIP DYKKLSFPEG FKWERVMNFE DGGVATVTQD SSLQDGCFIY 120 KVKFIGVNFP SDGPVMQKKT MGWEASTERL YPRDGVLKGE THKALKLKDG GHYLVEFKSI 180 YMAKKPVQLP GYYYVDAKLD ITSHNEDYTI VEQYERTEGR HHLFL 225 &lt;210〉 4 &lt;211&gt; 3261 &lt;212&gt; DNA &lt;213&gt; &lt;220&gt; &lt;223&gt; 人工序列 &lt;400&gt; 4 201114894atgctgtgaa aaaatgttaa attgactaac caaatctctg cagggagtat taattcctca tctagcctga ttgggggatg atgaaaaagt aggcttagtc gtgtattttt atctgtcttt acattagatt accttttcaa tattagtgcc ccttgaggtt cccagtgaca caaaataact aatattaaat aattgttcaa gttttatctt tctgttttgt tattcatttt taggtactgt ccgacagact aagggggaca gattgtttag actgtcttaa tagtgtgctg agcttcccac cggcagagag gggtgtggtg aaaacctatt tatatatcag ctggattgaa caagataagc tttagactct caaacagtcc gtattctcta atgaagggat agcaattcag gacaactaca actacaatat atcaaatatc tctcaagaga agcaaatcat tacaaatttg cctttattaa tatgcagcgg taaattaata agtcagtaca aaggtacata taaaaatttt ttattatgga gtttacaccc tatgataacg acaaatttta aatttgtagg tcaattttgt ttaaatgcac caaaatgggc aaaataatgc cacaggatat aaacagtgac ctattttggt gcctcaaatt accatctaaa aaatggcacc agagagagag ggggcacttg ttcgattagg ccaggggcgt atccatcagg cagtattgat gtggctacag cttacgtccc cttatcttaa attttcaaag ctacaattca tactaattga aaatacgata accccatatg aaacgcgagt actaaaatgt tgttgacccc tcaggattcg atgcccatcc tttttaatag ctctcagaaa tttgtactta aagagaaaca cctttaaggt tttatttctg gtccaaaaac aaacagggaa ttgtaatttt gactaaaata caaaatacat tgtactcgat taatcttaaa caaattagtc tgatgaatta cacccacagc tctcttcatg aactgggaaa tcacagtcac agagagagag aaccgaaatc gctgatttga gaacaaatat atctatcact ctgctgctaa ctcattcatt catgtcctta ttctctaaaa ccaatcgact agtaatgttc tgattagttt aaacttgtga tcccatgctc attttatgtt acgaattagt tcacaaatct ccacagagga agttgcagcc gaagctatac taaaggtgcg aagggtccat cttttgtact acaaattttt agagtgaagc tactacaccc aaatcaagag tttgttgcaa ttattttaat tgcctatatt tactctgagc caattttgga taaagaaaga gacaagaaaa tgttccttat agggtccaac aaggggtaat tgaagtgacc agtgctgaat ttacagcatc aataagggtt gaacaacata gcaaccctcc tctaacttta tcaaattgag ttagtcaacg ataatgcaaa tttagaatag tgaagataga aaacctatta gcatgtatta agcatatatg tcgtacgaat gtcttcattc atgagccacc ctacactggg aatgttatat caagctgtca attgatacct ttttaggtac atcatttgga taaatctgga atatttatat aagcaaaaca tatttagctt aaatatagct cactgagaga actgtaatta acaagaagga agggaatgca agagagcaag gcctgccttc atcaaccact tacgtgcttg gggtgaggt ttgccagttt c atgggcatgg actatactag aagacaccag atcattggct ccatccaaca ggggagggag ttatgtgatt cgagacatgc agtattcttt ataatgttta tatgagttaa ttttacatta aagcaattaa agtacacccc agttcagtca tagccactaa attttctttt aactcatcca aaacacccaa ttgtgcatat ctgcggtggt caaaagtata taatatatac aaggtaccac gcttatttaa gttattgaaa atggaaaaaa tatttaaatt gtttaataaa tggagaaaaa tctgtttttc gcaaaacaag caacaaactc gagcgctcaa ccaaaaaaaa cagagggctg tccacagggc ataggtcgat ccatgtggac gaaaagcatt aacgtcctct caaaaaatct agtaatcctg ttgcgtcccc gtatgaagct aggccgctgc 60 120 180 240 300 360 420 480 540 600 660 720 780 840 900 960 1020 1080 1140 1200 1260 1320 1380 1440 1500 1560 1620 1680 1740 1800 1860 1920 1980 2040 2100 2160 2220 2280 1 201114894 catcagtatc agattcatcc cattccaaga ctccaatagc tatttctgag cactgtaaga 2340 tgatagtaca tcccagccgg tgtccctcca tcactttccc cctacctcat agttttgcct 2400 ctttctctct cggtctgcta tttcccaaac ctcacttaag gttgggtcta taattcgcaa 2460 ggggccttcg tcagtatata agcccctcaa gtacaggaca ctac 2504 &lt;210&gt; 2 &lt;211&gt; 678 &lt;212&gt ; DNA &lt; 213 &gt; &lt; 220> &lt; 223 &gt; red fluorescent nucleotide sequence &lt; 400 &gt; 2 atggcctcct ccgagaacgt catcaccgag ttcatgcgct tcaaggtgcg catggagggc 60 accgtgaacg gccacgagtt 120 cacaacaccg cgagatcgag ggcgagggcg agggccgccc ctacgagggc tgaagctgaa ggtgaccaag ggcggccccc tgcccttcgc ctgggacatc 180 ctgtcccccc agttccagta cggctccaag gtgtacgtga agcaccccgc cgacatcccc 240 gactacaaga agctgtcctt ccccgagggc ttcaagtggg agcgcgtgat gaacttcgag 300 gacggcggcg tggcgaccgt gacccaggac tcctccctgc aggacggctg cttcatctac 360 aaggtgaagt tcatcggcgt gaacttcccc tccgacggcc ccgtgatgca gaagaagacc 420 atgggctggg aggcctccac cgagcgcctg tacccccgcg acggcgtgct gaagggcgag 480 acccacaagg ccctgaagct gaaggacggc ggccactacc tggtggagtt caagtccatc 540 tacatggcca agaagcccgt gcagctgccc ggctactact acgtggacgc caagctggac 600 atcacctccc acaacgagga ctacaccatc gtggagcagt Acgagcgcac cgagggccgc 660 caccacctgt tcctgtag 678 &lt;210>3 &lt;211&gt; 225 &lt;212&gt;Protein&lt;213&gt;&lt;220&gt;&lt;223&gt; Red fluorescylamino acid sequence &lt;400&gt; 3 MASSE NVITE FMRFKVRMEG TVNGHEFEIE GEGEGRPYEG HNTVKLKVTK GGPLPFAWDI 60 LSPQFQYGSK VYVKHPADIP DYKKLSFPEG FKWERVMNFE DGGVATVTQD SSLQDGCFIY 120 KVKFIGVNFP SDGPVMQKKT MGWEASTERL YPRDGVLKGE THKALKLKDG GHYLVEFKSI 180 YMAKKPVQLP GYYYVDAKLD ITSHNEDYTI VEQYERTEGR HHLFL 225 &lt; 210> 4 &lt; 211 &gt; 3261 &lt; 212 &gt; DNA &lt; 213 &gt; &lt; 220 &gt;&lt;223&gt; Artificial sequence &lt;400&gt; 4 201114894

gaattcgccc ataatgcaaa tttagaatag tgaagataga aaacctatta gcatgtatta agcatatatg ttgccagttt tcgtacgaat gtcttcattc atgagccacc ctacactggg aatgttatat caagctgtca attgatacct ttttaggtac atcagttgga taaatctgga atatttatat aagcaaaaca tatttagctt aaatatagct cactgagaga actgtaatta acaagaagga agggaatgca agagagcaag gcctgccttc tcaaccactc acgtgcttgt ggtgaggtca catggccatg actaggaaaa accagaacgt tggctcaaaa caacaagtaa gggagttgcg tgattgtatg catgcaggcc ctgagcactg ctcatagttt gtctataatc ctagccgaag accatggcct ttcgctcgag agtattcttt ataatgttta tatgagttaa ttttacatta aagcaattaa agtacacccc agttcagtca tagccactaa attttctttt aactcatcca aaacacccaa ttgtgcatat ctgcggtggt caaaagtata taatatatac aaggtaccac gcttatttaa gttattgaaa atggaaaaaa tatttaaatt gtttaataaa tggggaaaaa tctgtttttc gcaaaacaag caacaaactc gagcgctcaa ccaaaaaaaa agagggctgt ccacagggca taggtcgatc tggacgggtg gcattaaaac cctcttatat aatctctgga tcctgcaaga tcccctttag aagctcaaac gctgccatca taagatgata tgcctctttc agcaaggggc ggcgaattct cctccgagaa atgctgtgaa aaaatgttaa attgactaac caaatctctg cagggagtat taattcctca tctagcctga ttgggggatg atgaaaaagt aggcttagtc gtgtattttt atctgtcttt acattagatt accttttcaa tactagtgcc ccttgaggtt cccagtgaca caaaataact aatattaaat aattgttcaa gttttatctt tctgttttgt tattcatttt taggtactgt ccgacagact aagggggaca gattgtttag ctgtcttaag agtgtgctga gcttcccaca ggcagagaga tggtgggggc ctattttcga atcagccagg ttgaaatcca taagccagta actctgtggc agtcccttac gtatcagatt gtacatccca tctctcggtc cttcgtcagt gcagtcgacg cgtcatcacc gtattctcta atgaagggat agcaattcag gacaactaca actacaatat atcaaatatc tctcaagaga agcaaatcat tacaaatttg cctttattaa tatgcagcgg taaattaata agtcagtaca aaggtacata taaaaatttt ttattatgga gtttacaccc tatgataacg acaaatttta aatttgtagg tcaattttgt ttaaatgcac caaaatgggc aaaataatgc cacaggatat aaacagtgac ctattttggt cctcaaattt ccatctaaaa aatggcacct gagagagaga acttgaaccg ttagggctga ggcgtgaata tcaggatcta ttgatctgct tacagctcat gtccccatgt catcccattc gccggtgtcc tgctatttcc atataagccc gtaccgcggg gagttcatgc cttatcttaa attttcaaag ctacaattca tactaattga aaatacgata accccatatg aaacgcgagt actaaaatgt tgttgacccc tcaggattcg atgcccatcc tttttaatag ctctcagaaa tttgtactta aagagaaaca cctttaaggt tttatttctg gtccaaaaac aaacagggaa ttgtaatttt gactaaaata caaaatacat tgtactcgat taatcttaaa caaattagtc tgatgaatta cacccacagc ctcttcatga actgggaaaa cacagtcact gagagagtgc aaatcttaca tttgaaataa aatatgaaca tcactgcaac gctaatctaa tcatttcaaa ccttattagt caagactcca ctccatcact caaacctcac ctcaagtaca cccgggatcc gcttcaaggt ttctctaaaa ccaatcgact agtaatgttc tgattagttt aaacttgtga tcccatgctc attttatgtt acgaattagt tcacaaatct ccacagagga agttgcagcc gaagctatac taaaggtgcg aagggtccat cttttgtact acaaattttt agagtgaagc tactacaccc aaatcaagag tttgttgcaa ttattttaat tgcctatatt tactctgagc caattttgga taaagaaaga gacaagaaaa tgttccttat gggtccaaca aggggtaatt gaagtgaccg tgaatatggg gcatcactat gggttaagac acataatcat cctccccatc ctttagggga ttgagttatg caacgcgaga atagctattt ttccccctac ttaaggttgg ggacactacg accggtcgcc gcgcatggag 60 120 180 240 300 360 420 480 540 600 660 720 780 840 900 960 1020 1080 1140 1200 1260 1320 1380 1440 1500 1560 1620 1680 1740 1800 1860 1920 1980 2040 2100 2160 2220 2280 2340 2400 2460 2520 2580 2640 201114894 ggcaccgtga acggccacga gttcgagatc gagggcgagg gcgagggccg cccctacgag 2700 ggccacaaca ccgtgaagct gaaggtgacc aagggcggcc ccctgccctt cgcctgggac 2760 atcctgtccc cccagttcca gtacggctcc aaggtgtacg tgaagcaccc cgccgacatc 2820 cccgactaca agaagctgtc cttccccgag ggcttcaagt gggagcgcgt gatgaacttc 2880 gaggacggcg gcgtggcgac egtgacccag gactcctccc tgcaggacgg ctgcttcatc 2940 tacaaggtga agttcatcgg cgtgaacttc ccctccgacg gccccgtgat gcagaagaag 3000 accatgggct gggaggcctc caccgagcgc ctgtaccccc gcgacggcgt gctgaagggc 3060 gagacccaca aggccctgaa gctgaaggac ggcggccact acctggtgga gttcaagtcc 3120 atctacatgg ccaagaagcc cgtgcagctg cccggctact actacgtgga cgccaagctg 3180 gacatcacct cccacaacga ggactacacc atcgtggagc agtacgagcg caccgagggc 3240 cgccaccacc tgttcctgta g 3261 &lt;210&gt; 5 &lt;211&gt; 31 &lt;212&gt; DNA &lt;213&gt;人工合成 &lt;220&gt; &lt;223&gt; DNA 引子(5, mylz2 2.5k Xhol) &lt;400&gt; 5 cgctcgagat gctgtgaagt attctctact t 31 &lt;210&gt; 6 &lt;211〉 31 &lt;212〉DNA &lt;213&gt;人工合成 &lt;220&gt; &lt;223&gt; DNA 引子(3' mylz2 2.5k Nhel) &lt;400&gt; 6 cggctagcgt agtgtcctgt acttgagggg c 31 &lt;210&gt; 7 &lt;211&gt; 28 &lt;212&gt; DNA &lt;213&gt;人工合成 &lt;220&gt; &lt;223〉DNA 引子(mylz2 2.5K 5' SacI) &lt;400&gt; 7 cggagctcat gctgtgaagt attctcta 28 201114894 &lt;210&gt; 8 &lt;211&gt; 28 &lt;212&gt; DNA &lt;213&gt; 人工合成 &lt;220&gt; &lt;223&gt; DNA引子(mylz2 2.3K5'SacI) &lt;400&gt; 8 cggagctcta ctaattgatg attagttt 28gaattcgccc ataatgcaaa tttagaatag tgaagataga aaacctatta gcatgtatta agcatatatg ttgccagttt tcgtacgaat gtcttcattc atgagccacc ctacactggg aatgttatat caagctgtca attgatacct ttttaggtac atcagttgga taaatctgga atatttatat aagcaaaaca tatttagctt aaatatagct cactgagaga actgtaatta acaagaagga agggaatgca agagagcaag gcctgccttc tcaaccactc acgtgcttgt ggtgaggtca catggccatg actaggaaaa accagaacgt tggctcaaaa caacaagtaa gggagttgcg tgattgtatg catgcaggcc ctgagcactg ctcatagttt gtctataatc ctagccgaag accatggcct ttcgctcgag agtattcttt ataatgttta tatgagttaa ttttacatta aagcaattaa agtacacccc agttcagtca tagccactaa attttctttt aactcatcca aaacacccaa ttgtgcatat ctgcggtggt caaaagtata taatatatac aaggtaccac gcttatttaa gttattgaaa atggaaaaaa tatttaaatt ccaaaaaaaa gtttaataaa tggggaaaaa tctgtttttc gcaaaacaag caacaaactc gagcgctcaa ggcgaattct cctccgagaa atgctgtgaa agagggctgt ccacagggca taggtcgatc tggacgggtg gcattaaaac cctcttatat aatctctgga tcctgcaaga tcccctttag aagctcaaac gctgccatca taagatgata tgcctctttc agcaaggggc aaaatgttaa attgactaac caaatctctg cagggagtat tctagcctga ttgggggatg atgaaaaagt aggcttagtc gtgtattttt atctgtcttt acattagatt accttttcaa tactagtgcc ccttgaggtt cccagtgaca caaaataact aatattaaat aattgttcaa gttttatctt tctgttttgt tattcatttt taggtactgt ccgacagact aagggggaca gattgtttag ctgtcttaag agtgtgctga gcttcccaca ggcagagaga tggtgggggc ctattttcga atcagccagg ttgaaatcca taagccagta actctgtggc agtcccttac gtatcagatt gtacatccca tctctcggtc cttcgtcagt gcagtcgacg cgtcatcacc gtattctcta atgaagggat agcaattcag gacaactaca actacaatat atcaaatatc tctcaagaga agcaaatcat tacaaatttg taattcctca cctttattaa tatgcagcgg taaattaata agtcagtaca aaggtacata taaaaatttt ttattatgga gtttacaccc tatgataacg acaaatttta aatttgtagg tcaattttgt ttaaatgcac caaaatgggc aaaataatgc cacaggatat aaacagtgac ctattttggt cctcaaattt ccatctaaaa aatggcacct gagagagaga acttgaaccg ttagggctga ggcgtgaata tcaggatcta ttgatctgct tacagctcat gtccccatgt catcccattc gccggtgtcc tgctatttcc atataagccc gtaccgcggg gagttcatgc cttatcttaa attttcaaag ctacaattca tactaattga aaatacgata accccatat g aaacgcgagt actaaaatgt tgttgacccc tcaggattcg atgcccatcc tttttaatag ctctcagaaa tttgtactta aagagaaaca cctttaaggt tttatttctg gtccaaaaac aaacagggaa ttgtaatttt gactaaaata caaaatacat tgtactcgat taatcttaaa caaattagtc tgatgaatta cacccacagc ctcttcatga actgggaaaa cacagtcact gagagagtgc aaatcttaca tttgaaataa aatatgaaca tcactgcaac gctaatctaa tcatttcaaa ccttattagt caagactcca ctccatcact caaacctcac ctcaagtaca cccgggatcc gcttcaaggt ttctctaaaa ccaatcgact agtaatgttc tgattagttt aaacttgtga tcccatgctc attttatgtt acgaattagt tcacaaatct ccacagagga agttgcagcc gaagctatac taaaggtgcg aagggtccat cttttgtact acaaattttt agagtgaagc tactacaccc aaatcaagag tttgttgcaa ttattttaat tgcctatatt tactctgagc caattttgga taaagaaaga gacaagaaaa tgttccttat gggtccaaca aggggtaatt gaagtgaccg tgaatatggg gcatcactat gggttaagac acataatcat cctccccatc ctttagggga ttgagttatg caacgcgaga atagctattt ttccccctac ttaaggttgg ggacactacg accggtcgcc gcgcatggag 60 120 180 240 300 360 420 480 540 600 660 720 780 840 900 960 1020 1080 1140 1200 1260 1320 138 0 1440 1500 1560 1620 1680 1740 1800 1860 1920 1980 2040 2100 2160 2220 2280 2340 2400 2460 2520 2580 2640 201114894 ggcaccgtga acggccacga gttcgagatc gagggcgagg gcgagggccg cccctacgag 2700 ggccacaaca ccgtgaagct gaaggtgacc aagggcggcc ccctgccctt cgcctgggac 2760 atcctgtccc cccagttcca gtacggctcc aaggtgtacg tgaagcaccc cgccgacatc 2820 cccgactaca agaagctgtc cttccccgag ggcttcaagt gggagcgcgt gatgaacttc 2880 gaggacggcg gcgtggcgac egtgacccag gactcctccc tgcaggacgg ctgcttcatc 2940 tacaaggtga agttcatcgg cgtgaacttc ccctccgacg gccccgtgat gcagaagaag 3000 accatgggct gggaggcctc caccgagcgc ctgtaccccc gcgacggcgt gctgaagggc 3060 gagacccaca aggccctgaa gctgaaggac ggcggccact acctggtgga gttcaagtcc 3120 atctacatgg ccaagaagcc cgtgcagctg cccggctact actacgtgga cgccaagctg 3180 gacatcacct cccacaacga ggactacacc atcgtggagc agtacgagcg caccgagggc 3240 cgccaccacc tgttcctgta g 3261 &lt; 210 & gt 5 &lt;211&gt; 31 &lt;212&gt; DNA &lt;213&gt; Synthetic &lt;220&gt;&lt;223&gt; DNA primer (5, mylz2 2.5k Xhol) &lt;400&gt; 5 cgct Cgagat gctgtgaagt attctctact t 31 &lt;210&gt; 6 &lt;211> 31 &lt;212>DNA &lt;213&gt; Synthetic &lt;220&gt;&lt;223&gt; DNA primer (3' mylz2 2.5k Nhel) &lt;400&gt; 6 cggctagcgt Agtgtcctgt acttgagggg c 31 &lt;210&gt; 7 &lt;211&gt; 28 &lt;212&gt; DNA &lt;213&gt; Synthetic &lt;220&gt;&lt;223&gt; DNA primer (mylz2 2.5K 5' SacI) &lt;400&gt; 7 cggagctcat gctgtgaagt Attctcta 28 201114894 &lt;210&gt; 8 &lt;211&gt; 28 &lt;212&gt; DNA &lt;213&gt; Synthetic &lt;220&gt;&lt;223&gt; DNA primer (mylz2 2.3K5'SacI) &lt;400&gt; 8 cggagctcta ctaattgatg attagttt 28

&lt;210&gt; 9 &lt;211&gt; 28 &lt;212&gt; DNA &lt;213&gt; 人工合成 &lt;220〉 &lt;223&gt; DNA引子(mylz2 2.1K5’SacI) &lt;400 9 28 cggagctctt gccagtttag ttcagtca &lt;210 10 &lt;211&gt; 28 &lt;212&gt; DNA &lt;213&gt; 人工合成 &lt;220〉 &lt;223&gt; DNA引子(mylz2 1 ·9Κ 5, SacI) &lt;400&gt; 10 cggagctcgt gtatttttta tgcagcgg 28 &lt;210〉 11 &lt;211&gt; 28 &lt;212&gt; DNA &lt;213&gt; 人工合成 &lt;220&gt; &lt;223&gt; DNA 引子(mylz2 promoter 3' Xhol) &lt;&gt;11 cgctcgaggt agtgtcctgt acttgagg 28 5&lt;210&gt; 9 &lt;211&gt; 28 &lt;212&gt; DNA &lt;213&gt; Synthetic &lt;220&gt;&lt;223&gt; DNA primer (mylz2 2.1K5'SacI) &lt;400 9 28 cggagctctt gccagtttag ttcagtca &lt;210 10 &lt;211&gt; 28 &lt;212&gt; DNA &lt;213&gt; Synthetic &lt;220&gt;&lt;223&gt; DNA primer (mylz2 1 ·9Κ 5, SacI) &lt;400&gt; 10 cggagctcgt gtatttttta tgcagcgg 28 &lt;210> 11 &lt;;211&gt; 28 &lt;212&gt; DNA &lt;213&gt; Synthetic &lt;220&gt;&lt;223&gt; DNA primer (mylz2 promoter 3' Xhol) &lt;&gt;11 cgctcgaggt agtgtcctgt acttgagg 28 5

Claims (1)

201114894 七、申請專利範圍: 1. 一種分離的核酸分子,其係由SEQIDN〇:1之核苷 酸序列所組成,其具有啟動子活性。 z種重組載體,其包含第一核酸片段,該第一核酸 片段係由SEQDD NO: 1之核苷酸序列所組成。 3·根據中請專利範圍第2項之重組載體,其進一步包 含第-核W段’其編碼蛋白質且操作地連結至第一核酸片 段。 4. 根據申請專利範圍第3項之重組載體,其中第二核 酸片段係編碼外源蛋白質或多肽。 5. 根據申請專利範圍第3項之重組載體,其中第二核 酸片段係編碼冷光或螢羌蛋白。 6. 根據申請專利範圍第3項之重組載體,其中第二核 酸片段係由SEQ ID NO: 2之核苷酸序列所組成。 7. 根據申請專利範圍第4項之重組載體,其包含SEQ ID NO: 4之核苷酸序列。 咏一種製備轉殖基因動物之方法,其包含將申請專利 範圍第3至7項中任一項之重組載體導入動物的配子、受精 卵、胚胎或體細胞的細胞核或細胞質内,使該重組載體所含之 核酸分子在胚胎或細胞中繼續複製,進而在個體及其後代細胞 上表現;其中該動物不包含人類。 9·根據申請專利範圍第8項之方法,其係用於製備轉 殖基因魚。 10.根據申請專利範圍第9項之方法’其係使用顯微注 射技術將該重組载體導入魚的受精卵中。 U_根據申请專利範圍第9項之方法,其中該魚係斑馬 魚。 14201114894 VII. Patent Application Range: 1. An isolated nucleic acid molecule consisting of the nucleotide sequence of SEQ ID NO: 1, which has promoter activity. A recombinant vector comprising a first nucleic acid fragment consisting of the nucleotide sequence of SEQ ID NO: 1. 3. The recombinant vector of claim 2, further comprising a first-nuclear W segment&apos; encoded protein and operably linked to the first nucleic acid fragment. 4. The recombinant vector according to claim 3, wherein the second nucleic acid fragment encodes a foreign protein or polypeptide. 5. The recombinant vector according to claim 3, wherein the second nucleic acid fragment encodes a luminescent or fluorescein protein. 6. The recombinant vector according to claim 3, wherein the second nucleic acid fragment consists of the nucleotide sequence of SEQ ID NO: 2. 7. The recombinant vector according to claim 4, which comprises the nucleotide sequence of SEQ ID NO: 4. A method for producing a transgenic animal, which comprises introducing the recombinant vector of any one of claims 3 to 7 into a nucleus or cytoplasm of a gametophyte, a fertilized egg, an embryo or a somatic cell of an animal, such that the recombinant vector The nucleic acid molecules contained therein continue to replicate in the embryo or cell and are then expressed on the individual and its progeny cells; wherein the animal does not comprise humans. 9. The method of claim 8, which is for the preparation of a transgenic fish. 10. The method according to claim 9 wherein the recombinant vector is introduced into a fertilized egg of a fish using a microinjection technique. U_ According to the method of claim 9, wherein the fish is a zebrafish. 14
TW98136948A 2009-10-30 2009-10-30 A novel promoter and applications thereof TWI396742B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW98136948A TWI396742B (en) 2009-10-30 2009-10-30 A novel promoter and applications thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW98136948A TWI396742B (en) 2009-10-30 2009-10-30 A novel promoter and applications thereof

Publications (2)

Publication Number Publication Date
TW201114894A true TW201114894A (en) 2011-05-01
TWI396742B TWI396742B (en) 2013-05-21

Family

ID=44934214

Family Applications (1)

Application Number Title Priority Date Filing Date
TW98136948A TWI396742B (en) 2009-10-30 2009-10-30 A novel promoter and applications thereof

Country Status (1)

Country Link
TW (1) TWI396742B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000049150A1 (en) * 1999-02-18 2000-08-24 National University Of Singapore Chimeric gene constructs for generation of fluorescent transgenic ornamental fish

Also Published As

Publication number Publication date
TWI396742B (en) 2013-05-21

Similar Documents

Publication Publication Date Title
Zhu et al. Reverse transcriptase template switching: A SMART™ approach for full-length cDNA library construction
CN109734798B (en) Migratory locust serine protease inhibitor 7, and coding gene and application thereof
CN112760324B (en) Method for improving silk yield of silkworms
CN111387105B (en) Method for producing seeds of all-male macrobrachium rosenbergii
CN108610427A (en) Migratory locusts diapause hormone gene and its application in regulating and controlling Insect Diapause
Gao et al. Transcriptome analysis of body wall reveals growth difference between the largest and smallest individuals in the pure and hybrid populations of Apostichopus japonicus
Kontarakis et al. Transgenesis in non-model organisms: the case of Parhyale
JP3723839B2 (en) Chicken leukemia inhibitory factor (LIF) and gene encoding the same
CN110747199B (en) Bee stress-resistance related gene NF-Y and application thereof
US20200149063A1 (en) Methods for gender determination and selection of avian embryos in unhatched eggs
CN112226465A (en) Application of isolated nucleotide sequence in construction of mineralizeless intermuscular bone zebra fish
CN104745584B (en) One kind is for disturbing arrenotokous nucleic acid molecules of Macrobrachium rosenbergii and preparation method thereof
CN114058618B (en) Application of glutamate dehydrogenase as target in pest control
WO2004053119A1 (en) Fluorescent proteins from aquatic species
CN112458080B (en) siRNA fishing method for obtaining lncRNA LOC157273
TW201114894A (en) A novel promoter and applications thereof
CN107267511B (en) RNAi interference fragment, interference vector, preparation method and application thereof
CN105063088B (en) A kind of method of production of ecological safety type fluorescent transgenic ornamental fish
KR101859029B1 (en) Caenorhabditis elegans displaying anti-aging phenotype
CN109438565B (en) Migratory locust forkhead transcription factor LmFoxO, and coding gene and application thereof
CN112725345B (en) dsRNA designed based on periplaneta americana sex pheromone receptor gene OR5M, coding gene, preparation method and application thereof
CN102911937B (en) Muscle enhancer sequence and application thereof
TWI375717B (en) Penaeidin gene promoters in tiger shrimp and applications thereof
CN106754952A (en) The subunit Beta-4 gene of Kirghiz Republic white birch chloroplaset chaperone 60 and its encoding proteins
Ma et al. High-throughput and genome-scale targeted mutagenesis using CRISPR in a nonmodel multicellular organism, Bombyx mori

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees